Nirbhay Kumar Tiwari

Author

Aurigene Discovery Technologies (India)

Also Known As

Nirbhay K. Tiwari, Nirbhay Kumar Tiwari, Nirbhay Tiwari

Publications

126

Citations

H-Index

Concepts

All Affiliations

Aurigene Discovery Technologies (India)Astellas Pharma (Japan)Dr. Reddy's Laboratories (India)IIT@MIT

About

Nirbhay Kumar Tiwari is an author at Aurigene Discovery Technologies (India) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	92
2	Pharmacology	5	5	92
3	Biochemistry	2	2	56
4	Biomolecular Engineering	1	1	10
5	Clinical Pharmacology	1	1	11

Nirbhay Kumar Tiwari

Publications

109

Citations

H-Index

Page 1

	Year	Citations
Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: Quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bile Jafar Sadik Shaik, Abdul Naveed Shaik, Nirbhay Kumar Tiwari, Journal of Chromatography B BiochemistryConcurrent DeterminationMedicineChromatographic AnalysisBioanalysis	2007	44
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD) Bharat Lagu, Arthur F. Kluge, Effie Tozzo, ACS Medicinal Chemistry Letters	2018	17
A validated LC–MS/MS method for the estimation of glimepiride and pitavastatin in rat plasma: Application to drug interaction studies Shruti Surendran, David Paul, Ratna Sushmita, Journal of Chromatography B Therapeutic Drug MonitoringPharmacokinetic ModelingMedicineBioanalysisValidated Lc–ms/ms Method	2017	15
Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516 Bharat Lagu, Arthur F. Kluge, Matthew M. Goddeeris, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicinePhysiologyPharmacologyImproved Safety Profile	2017	12
Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing Bharat Lagu, Arthur F. Kluge, Ross A. Fredenburg, Bioorganic & Medicinal Chemistry Letters PhysiologyPharmacologyPharmacological AgentClinical PharmacologyPharmacotherapy	2017	11
Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists Pradip K. Sasmal, C. Vamsee Krishna, S. Sudheerkumar Adabala, Bioorganic & Medicinal Chemistry Letters Drug TargetFunctional SelectivityMedicineDrug DiscoveryMechanism Of Action	2015	10

Page 1